SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ho, M.-Y.
Right arrow Articles by Szabadi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, M.-Y.
Right arrow Articles by Szabadi, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

5-Hydroxytryptamine and impulse control: prospects for a behavioural analysis

M.-Y. Ho

Department of Psychiatry, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH UK.

S.S.A. Al-Zahrani

Department of Psychiatry, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH UK.

A.S.A. Al-Ruwaitea

Department of Psychiatry, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH UK.

C.M. Bradshaw

Department of Psychiatry, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH UK.

E. Szabadi

Department of Psychiatry, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH UK.

Impulsiveness is a significant clinical problem associated with a variety of psychiatric and neuropsychiatric disorders. Clinical and experimental studies have provided evidence that individuals displaying impulsive behaviour tend to show signs of deficient functioning of the ascending 5-hydroxytryptaminergic (5-HTergic) pathways of the brain. A persistent problem in investigations of the biological basis of impulsive behaviour has been the lack of a satisfactory definition of 'impulsiveness', as distinct from other behavioural features, such as aggression, which are often apparent in 'impulsive' individuals. Research in the experimental analysis of behaviour suggests that two important characteristics of 'impulsiveness' are (i) deficient tolerance of delay of gratification and (ii) inability to inhibit or delay voluntary behaviour; both of these characteristics are amenable to study in laboratory animals. We describe some delayed reinforcement and delayed response paradigms which purport to capture these behavioural characteristics, and review recent evidence that manipulation of 5-HTergic function alters behaviour in these paradigms. It is argued that the two characteristics of 'impulsiveness' are themselves the product of disturbance of more fundamental behavioural processes; the nature of these processes is considered.

Key Words: 5-hydroxytryptamine • impulsiveness • self-control • timing

Journal of Psychopharmacology, Vol. 12, No. 1, 68-78 (1998)
DOI: 10.1177/026988119801200109


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
I. M. Anderson, R. A. Richell, and C. M. Bradshaw
The effect of acute tryptophan depletion on probabilistic choice
J Psychopharmacol, January 1, 2003; 17(1): 3 - 7.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
A. J. Goudie
What is the clinical significance of the discontinuation syndrome seen with clozapine?
J Psychopharmacol, March 1, 2000; 14(2): 188 - 190.
[PDF]


Home page
J PsychopharmacolHome page
J. Evenden
Impulsivity: a discussion of clinical and experimental findings
J Psychopharmacol, March 1, 1999; 13(2): 180 - 192.
[Abstract] [PDF]



Advertisement